View of NCT03108664 on 2018_01_24
ClinicalTrials Identifier: NCT03108664
Updated: 2018_01_24
Brief Summary:
The purpose of this study is to determine whether SYL1001 ophthalmic solution is safe and effective in the treatment of signs and symptoms of Dry Eye Disease.
Study Design
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 300 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye
Actual Study Start Date : May 18, 2017 .
Estimated Primary Completion Date :
March 2018 ( Anticipated ).
Estimated Study Completion Date :
December 2018 ( Anticipated ).
